JANSSEN PHARMACEUTICA N.V. - BE 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:600-700
2019
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:> 1000
Total Number of Projects:100-200
2018
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:> 1000
Total Number of Projects:400-500
Networking Rank (Reputation):700-800
2017
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:500-600
Total Number of Projects:500-600
Networking Rank (Reputation):400-500
2016
Criterium:Position:
Overall Score:800-900
Networking Rank (Reputation):700-800
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2015-01-01 - 2021-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 72
As coordinator: 1
As participant: 71
Sole participant: 0
Coordinator / Participant Ratio: 0.01*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 175.920.584 2.296.409 12
2020 0 154.106.951 255.250 6
2019 0 227.020.318 681.640 21
2018 2.054.499 164.854.672 134.531 1 6
2017 0 100.465.984 1.270.035 12
2016 0 82.314.814 430.674 11
2015 0 11.045.925 501.120 3

Networking:

Partners:

Institution:Projects [No]:
NOVARTIS PHARMA27
PFIZER LIMITED24
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD23
ELI LILLY AND COMPANY LIMITED19
F HOFFMANNLA ROCHE19
BAYER17
SANOFIAVENTIS17
KATHOLIEKE UNIVERSITEIT LEUVEN16
UCB BIOPHARMA16
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE13
TAKEDA PHARMACEUTICALS INTERNATIONAL13
ASTRAZENECA12
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM12
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V12
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT12
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN12
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL12
TAKEDA DEVELOPMENT CENTRE EUROPE12
CHARITE UNIVERSITAETSMEDIZIN BERLIN11
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE11
NOVO NORDISK11
STICHTING VUMC11
UNIVERSITY COLLEGE LONDON11
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG10
KING'S COLLEGE LONDON10
THE UNIVERSITY OF EDINBURGH10
UPPSALA UNIVERSITET10
ABBVIE INC9
KAROLINSKA INSTITUTE9
STICHTING LYGATURE9
UNIVERSITAIR MEDISCH CENTRUM UTRECHT9
ACADEMISCH ZIEKENHUIS GRONINGEN8
H LUNDBECK AS8
MEDIZINISCHE UNIVERSITAET WIEN8
UNIVERSITY OF NEWCASTLE UPON TYNE8
ALZHEIMER EUROPE7
ASTELLAS PHARMA EUROPE BV7
ASTRAZENECA AB7
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE7
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS7
INSTITUT DE RECHERCHES SERVIER7
LEIDS UNIVERSITAIR MEDISCH CENTRUM7
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE7
STICHTING KATHOLIEKE UNIVERSITEIT7
UNIVERSITY OF DUNDEE7
COMMISSARIAT A L'ENERGIE ATOMIQUE6
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN6
SERVICIO MADRILENO DE SALUD6
THE UNIVERSITY OF LIVERPOOL6
THE UNIVERSITY OF MANCHESTER6
ACADEMISCH ZIEKENHUIS LEIDEN5
EUROPEAN CANCER PATIENT COALITION5
FORUM DES PATIENTS EUROPEENS5
GOETEBORGS UNIVERSITET5
MERCK SHARP & DOHME CORP5
ORION OYJ5
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT5
TEVA PHARMACEUTICAL INDUSTRIES LIMITED5
UNIVERSITA VITASALUTE SAN RAFFAELE5
UNIVERSITE DE GENEVE5
UNIVERSITEIT ANTWERPEN5
UNIVERSITEIT MAASTRICHT5
UNIVERSITY OF CAMBRIDGE5
UNIVERSITY OF COPENHAGEN5
UNIVERSITY OF GLASGOW5
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS4
BAYER AKTIENGESELLSCHAFT4
BIOGEN IDEC LIMITED4
CELGENE MANAGEMENT SARL4
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS4
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV4
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS4
EUROPEAN MOLECULAR BIOLOGY LABORATORY4
FONDAZIONE PENTA FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES ONLUS4
INSTITUT PASTEUR4
KLINIKUM DER UNIVERSITAET ZU KOELN4
LEIDEN UNIVERSITY4
OSPEDALE PEDIATRICO BAMBINO GESU4
RIJKSUNIVERSITEIT GRONINGEN4
SANOFIAVENTIS DEUTSCHLAND4
STICHTING BURO ECNP4
THE HYVE BV4
THE UNIVERSITY OF SHEFFIELD4
TTOPSTART BV4
UNIVERSIDAD POMPEU FABRA4
UNIVERSITAETSKLINIKUM HEIDELBERG4
UNIVERSITAT WIEN4
UNIVERSITE D'AIX MARSEILLE4
UNIVERSITE DE BORDEAUX4
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK4
UNIVERSITY OF BIRMINGHAM4
UNIVERSITY OF BOLOGNA4
ABBVIE DEUTSCHLAND GMBH & CO KG3
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN3
ARTTIC3
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION3
BAYER PHARMA3
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM3
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL3
CENTRE DE RECHERCHE PUBLIC DE LA SANTE3

Constancy:

Total number of partners: 1658
Partner loyalty:
Frequent Partner: (> 2 projects): 881
Rare Partner: 777
Frequent / Rare Partner Ratio: 1.13

Project overview:

Start dateProjectacronymrolefundingpartners
2021-11-01European platform for neurodegenerative disorders EPNDparticipant9.680.00029
2021-11-01Preparing for RSV Immunisation and Surveillance in Europe PROMISEparticipant3.744.37522
2021-09-01Allostery in Drug Discovery ALLODDparticipant3.669.35413
2021-09-01BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe BEAMERparticipant5.948.90330
2021-06-01Using real-world big data from eHealth, biobanks and national registries, integrated with clinical trial data to improve outcome of severe mental disorders REALMENTparticipant6.000.00015
2021-06-01ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS UNITE4TBparticipant92.500.00032
2021-02-01Central Repository for Digital Pathology BIGPICTUREparticipant32.319.82548
2021-01-01A fully integrated, animal-free, end-to-end modelling approach to oral drug product development InPharmaparticipant3.475.40211
2021-01-01Drug repurposing and discovery multidisciplinary training network DRUGtrainparticipant2.394.8178
2021-01-01Advanced machine learning for Innovative Drug Discovery AIDDparticipant3.926.61515
2021-01-01Boosting advanced doctoral training in innovative colon targeting drugs COLOTANparticipant3.533.10810
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18529
2020-11-01Accelerating Research & Development for Advanced Therapies ARDATparticipant11.773.00034
2020-05-01Process Analytical Technology Tools for Real-Time Physical and Chemical Characterization of Nanosuspensions PAT4Nanoparticipant5.092.4099
2020-04-01Swift COronavirus therapeutics REsponse SCOREparticipant2.576.06310
2020-04-01Corona Accelerated R&D in Europe CAREparticipant36.559.18642
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69429
2020-01-01EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS ERA4TBparticipant89.815.60032
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95337
2019-11-01Collaboration for Prevention and Treatment of MDR Bacterial Infections COMBINEparticipant8.000.00011
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52347
2019-10-01A Centre of Excellence in Computational Biomedicine CompBioMed2participant7.992.82316
2019-10-01Long Acting Medicines for Complex Therapeutics Needed Now LongActNowparticipant1.292.9013
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00023
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-05-01Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors RespiriTBparticipant6.840.0009
2019-05-01Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs RespiriNTMparticipant5.687.9849
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-04-01The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use VALUE-Dxparticipant6.799.10026
2019-03-01Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts IMMUcanparticipant17.830.00028
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64818
2019-03-01Efficiently Networking European Neurodegeneration Research NEURONETparticipant1.199.12510
2019-02-01Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease TransBioLineparticipant13.999.99829
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027
2019-01-01Remote Assessment of Disease and Relapse – Alzheimer’s Disease RADAR-ADparticipant4.999.75717
2019-01-01Multiscale Analysis of Thermomechanical Behaviour of Granular Materials MatheGramparticipant4.170.17815
2019-01-01FAIRplus FAIRplusparticipant3.996.15022
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320
2018-11-01Artificial Intelligence to transform Drug and Chemical safety testing PATH-TOXcoordinator2.054.4993
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-06-01Autism Innovative Medicine Studies – 2 – Trials AIMS-2-TRIALSparticipant54.999.99948
2018-05-01Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope PIONEERparticipant6.000.00034
2018-05-01conect4children (COllaborative Network for European Clinical Trials For Children) c4cparticipant67.000.00047
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93135
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-10-01Memory research: Ground-breaking, Applied, and Technological Exchanges M-GATEparticipant3.961.16011
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2017-09-01Personalised In-Silico Cardiology PICparticipant4.000.56919

overview shows latest 50 from 72 projects (2015-01-01 - 2021-12-31)
A full list of projects can be found here: